State Street’s Oncorus, Inc. ONCR Stock Holding History

State Street’s Portfolio ONCR Stock Details ONCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-70,135	Closed	-$24.1K	–	4769
2023 Q1	$24.1K	Hold	70,135	–	–	﹤0.01%	4653
2022 Q4	$17.8K	Hold	70,135	–	–	﹤0.01%	4754
2022 Q3	$60K	Hold	70,135	–	–	﹤0.01%	4621
2022 Q2	$88K	Sell	70,135 -248,947	-78%	-$338K	﹤0.01%	4576
2022 Q1	$568K	Sell	319,082 -8,727	-3%	-$24.4K	﹤0.01%	3993
2021 Q4	$1.73M	Buy	327,809 +30,660	+10%	+$237K	﹤0.01%	3683
2021 Q3	$2.77M	Buy	297,149 +42,310	+17%	+$483K	﹤0.01%	3523
2021 Q2	$3.52M	Buy	254,839 +156,253	+158%	+$2.41M	﹤0.01%	3392
2021 Q1	$1.37M	Buy	98,586 +8,766	+10%	+$181K	﹤0.01%	3556
2020 Q4	$2.9M	Buy	+89,820	New	+$2.08M	﹤0.01%	3208

Other funds holding ONCR

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

YAL

Your Advocates Ltd Houston, Texas $350M AUM 21.03% 1-Year Est. Return

State Street's ONCR Position: Q2 2023 in Review

State Street sold out of Oncorus, Inc. (ONCR) in Q2 2023, closing a stake of 70,135 shares — an estimated $24.1K sold.

State Street first reported a position in ONCR in Q4 2020 and held it in 10 quarters. The position peaked at $3.52M in Q2 2021. 4 funds tracked by Wall St. Rank hold ONCR as of Q2 2023.

State Street reported no remaining Oncorus, Inc. position as of Q2 2023 after selling out during the quarter.
State Street sold 70,135 Oncorus, Inc. shares in Q2 2023, an estimated $24.1K.
State Street first reported a position in Oncorus, Inc. in Q4 2020 and held it in 10 quarters.
State Street's Oncorus, Inc. position peaked at $3.52M in Q2 2021.
4 funds tracked by Wall St. Rank held Oncorus, Inc. as of Q2 2023.

Based on State Street's 13F filing for Q2 2023, filed 14 Aug 2023.